The company has heard from the FDA. The statement reads.
request an immediate trading halt in the securities of the Companypending release of an announcement regarding US Food and Drug Administration (FDA)communication in respect of the Botanix New Drug Application (NDA) for Sofpironium Bromide gel,for the treatment of primary axillary hyperhidrosis (excessive sweating)
In other words the trading halt is with regards to the communication received from the FDA.
Ann: Trading Halt, page-23
-
- There are more pages in this discussion • 294 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
-0.005(1.39%) |
Mkt cap ! $645.1M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.5¢ | 35.5¢ | $1.731M | 4.833M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 105638 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 215555 | 4 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |